Health Systems, Economic Evaluations, Quality of Life

Moving in medRxiv, New England Journal of Medicine, Environmental research, Nature Biotechnology, Nature Genetics and The Lancet Oncology.

Moved, week to 23 Oct 2026: 0
Papers in 60 days: 14

Add Health Systems, Economic Evaluations, Quality of Life as an interest in JClubFree on iPhone and Android · interests shape Home, Discover and your digest

Rebuilt 23 October 2026 at 8:04 pm AEDT

Moved this week

Everything that moved →

Nothing in this topic has moved yet this week.

Latest in Health Systems, Economic Evaluations, Quality of Life

Newest first · last 60 days

Standardized country-level delivery unit cost estimates for routine childhood, routine adolescent, and campaign vaccination: an updated modeling analysis
medRxiv · 22 Oct 2026 · Preprint
Read the AI summary in JClub
- Open access
- 1 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.64898/2026.03.15.26348434
Open in JClub
Improving Survival Prediction from Surrogate Endpoints Through Integration of Patient-Reported Outcomes Using Machine Learning
medRxiv · 21 Oct 2026 · Preprint
Read the AI summary in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.1101/2025.10.02.25337154
Open in JClub
Determining context-specific economically feasible age ranges for female HPV catch-up vaccination in LMICs: a model-based health economic assessment
medRxiv · 20 Oct 2026 · Preprint
A one-time HPV catch-up vaccination campaign targeting females aged 9-30 in 132 LMICs could prevent nearly 7 million cervical cancer cases and over 3.5 million deaths, with cost-effectiveness varying by country.
- Open access
- 1 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.64898/2026.03.26.26348394
Open in JClub
Updated Health Opportunity Cost Estimates for 92 Low- and Middle-Income Countries: Implications for Global Health Financing and Donor Allocation
medRxiv · 15 Oct 2026 · Preprint
Read the AI summary in JClub
- Open access
- 1 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.64898/2026.03.31.26349880
Open in JClub
Joint Clinical Assessments - A New Chapter in European Pharmaceutical Policy.
New England Journal of Medicine · 1 Oct 2026 · Journal Article
Read the AI summary in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42804610
Open in JClub
Development and validation of early warning scores predicting 24-hour mortality addressing intercurrent medical interventions: a multi-centre retrospective cohort study of 2,08 million hospital encounters
medRxiv · 1 Oct 2026 · Preprint
Read the AI summary in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.1101/2025.10.12.25337794
Open in JClub
Beyond mortality: A multi-outcome assessment of health economic benefits from air pollution control in China.
Environmental research · 1 Oct 2026 · Journal Article
Read the AI summary in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42624321
Open in JClub
Balancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population.
The Lancet Oncology · 1 Oct 2026 · Review
Expanding cancer susceptibility testing beyond genetics clinics to the general population requires a careful, context-specific approach due to uncertain evidence for many genes and risk scores.
- 1 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42790443
Open in JClub
A Generalizable, Governance-Embedded Pathway for Assessing Patient-Level Opportunities for Genetic Medicines
medRxiv · 26 Sept 2026 · Preprint
Read the AI summary in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.64898/2026.09.22.26363712
Open in JClub
High-Throughput Observational Evidence Generation Using Linked Electronic Health Record and Claims Data
medRxiv · 18 Sept 2026 · Preprint
Read the AI summary in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.64898/2026.04.07.26350300
Open in JClub
The Future of the USPSTF and Evidence-Based Recommendations.
New England Journal of Medicine · 10 Sept 2026 · Journal Article
Read the AI summary in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42708473
Open in JClub
Applying the FDA's plausible mechanism guidance across the rare disease landscape.
Nature Genetics · 9 Sept 2026 · Journal Article
Read the AI summary in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42717240
Open in JClub
Lessons from drug revenue life cycles: distributions across modalities and therapeutic areas.
Nature Biotechnology · 1 Sept 2026 · Journal Article
Read the AI summary in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42613383
Open in JClub
Which outcomes of pharmacist-involved services are measured well enough to support decisions? A systematic review, meta-analysis, and evidence map of 266 randomised trials in China
medRxiv · 31 Aug 2026 · Preprint
Read the AI summary in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.1101/2024.07.25.24310734
Open in JClub

Add Health Systems, Economic Evaluations, Quality of Life as an interest in JClub

Journals this month

All journals →

Topics moving, week to 23 Oct 2026

All topics →

By field

All journals by field →

Moved this week

Latest in Health Systems, Economic Evaluations, Quality of Life

Browse JClub